menu

Assessing Advancements in Early Breast Cancer Therapy

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Assessing Advancements in Early Breast Cancer Therapy

close
Assessing Advancements in Early Breast Cancer Therapy
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    How have locoregional, adjuvant, and neoadjuvant therapies for early breast cancer changed? Dr. Mamounas, Medical Director of the Comprehensive Breast Program at Orlando Health UF Health Cancer Center, tells us about therapeutic developments for early breast cancer that were discussed at the 2020 San Antonio Breast Cancer Symposium.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    How have locoregional, adjuvant, and neoadjuvant therapies for early breast cancer changed? Dr. Mamounas, Medical Director of the Comprehensive Breast Program at Orlando Health UF Health Cancer Center, tells us about therapeutic developments for early breast cancer that were discussed at the 2020 San Antonio Breast Cancer Symposium.

Facebook Comments

Programs 5/10/21